Literature DB >> 20309776

Lay views about medicines: the influence of the illness label for the use of generic versus brand.

Maria João Figueiras1, Maria Armanda Cortes, Dália Marcelino, John Weinman.   

Abstract

The aim of this cross-sectional study was to investigate how different types of prescriptions using different illness labels may influence lay views about the use of generic or brand medicines. The participants were 882 Portuguese (both sexes) recruited from the general population, who completed a self-administered questionnaire. A vignette methodology was used in which different prescriptions (generic versus brand) were given for the same label (flu, hypertension, asthma and angina pectoris). The dependent variables were for each illness label: (a) the level of agreement with the prescription, (b) beliefs about the efficacy of a medicine and (c) beliefs about the relief of symptoms. There were main effects of the label and the type of prescription upon beliefs about the use of medicines. There were interactions between illness label and type of medicines. Labels which were perceived as more serious were associated with a lower belief in generic medicines. These results raise important questions concerning the need to consider illness perceptions of lay people (including perceived severity) and its relationship with perceptions of treatment for different conditions. Furthermore, these results may have implications for health-related behaviour in general, and in particular for communication between lay people and health professionals, prescribing behaviour, health costs and adherence to treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309776     DOI: 10.1080/08870440903137170

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  8 in total

1.  Association of lifestyle elements with self-rated wellness and health status in patients with Behcet's disease.

Authors:  Maryam Masoumi; Reihane Tabaraii; Saeed Shakiba; Mansoureh Shakeri; Abbas Smiley
Journal:  BMC Rheumatol       Date:  2020-09-27

2.  Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011.

Authors:  Keri Sewell; Susan Andreae; Elizabeth Luke; Monika M Safford
Journal:  Prev Chronic Dis       Date:  2012       Impact factor: 2.830

3.  Cognitive and affective determinants of generic drug acceptance and use: cross-sectional and experimental findings.

Authors:  Simone Dohle; Michael Siegrist
Journal:  Health Psychol Behav Med       Date:  2013-06-11

Review 4.  Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

Authors:  Robert J Straka; Denis J Keohane; Larry Z Liu
Journal:  Am J Ther       Date:  2017-05       Impact factor: 2.688

5.  Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.

Authors:  Rishi J Desai; Ameet Sarpatwari; Sara Dejene; Nazleen F Khan; Joyce Lii; James R Rogers; Sarah K Dutcher; Saeid Raofi; Justin Bohn; John G Connolly; Michael A Fischer; Aaron S Kesselheim; Joshua J Gagne
Journal:  PLoS Med       Date:  2019-03-13       Impact factor: 11.069

6.  Does illness perception associate with disease symptoms in Behçet's disease?

Authors:  Gonca Mumcu; Fedayi Yağar; Fatma Alibaz-Öner; Nevsun İnanç; Haner Direskeneli; Tulin Ergun
Journal:  Intern Emerg Med       Date:  2018-11-30       Impact factor: 3.397

Review 7.  A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-05       Impact factor: 2.483

8.  What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey.

Authors:  Kate MacKrill; Keith J Petrie
Journal:  BMJ Open       Date:  2018-10-18       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.